Gating on CD45+ cells and probing for CD19+/CD5+ and CD19+/B220dim cell populations, a progressive expansion of circulating CLL-like B-cells were detected as early as 5 months of age in both Eμ-MTCP1 founder lines (Fig. 2A). Here, PTPRC is linked to B-cell chronic lymphocytic leukemia.